Literature DB >> 1582084

The role of proteolytic enzymes in cancer invasion and metastasis.

M J Duffy1.   

Abstract

The production of metastasis appears to involve a number of different proteases including the urokinase form of plasminogen activator, cathepsin B, cathepsin D and various metalloproteases. Early data implicating these proteases in metastasis were mostly indirect and based on correlation studies in animal models. More recent work, using specific protease inhibitors and antibodies against proteases to block experimental metastasis, have provided more direct evidence that proteases play a role in cancer spread. In addition, transfection of genes encoding certain proteases increases the metastatic phenotype of the recipient cells. In human tumours, a number of different proteases also correlate with metastatic potential. It is concluded that certain proteases may be new prognostic markers in cancer as well as new targets for anti-metastatic therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582084     DOI: 10.1007/bf00132746

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  96 in total

1.  Tissue-type plasminogen activator in breast cancer: relationship with estradiol and progesterone receptors.

Authors:  M J Duffy; P O'Grady; J Simon; M Rose; H R Lijnen
Journal:  J Natl Cancer Inst       Date:  1986-09       Impact factor: 13.506

2.  Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer.

Authors:  F Jänicke; M Schmitt; H Graeff
Journal:  Semin Thromb Hemost       Date:  1991-07       Impact factor: 4.180

3.  Cathepsin D: an independent prognostic factor for metastasis of breast cancer.

Authors:  F Spyratos; T Maudelonde; J P Brouillet; M Brunet; A Defrenne; C Andrieu; K Hacene; A Desplaces; J Rouëssé; H Rochefort
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

Review 4.  Clinical and experimental studies on the biology of metastasis.

Authors:  D Tarin
Journal:  Biochim Biophys Acta       Date:  1985

5.  Involvement of plasminogen activator production with tumor metastasis in a rat model.

Authors:  S A Carlsen; I A Ramshaw; R C Warrington
Journal:  Cancer Res       Date:  1984-07       Impact factor: 12.701

6.  Human ovarian tumor-associated trypsin. Its purification and characterization from mucinous cyst fluid and identification as an activator of pro-urokinase.

Authors:  E Koivunen; M L Huhtala; U H Stenman
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

7.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

8.  Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.

Authors:  H R Yu; R M Schultz
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

9.  Antibodies to plasminogen activator inhibit human tumor metastasis.

Authors:  L Ossowski; E Reich
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

10.  Differential protease expression by cutaneous squamous and basal cell carcinomas.

Authors:  A P Sappino; D Belin; J Huarte; S Hirschel-Scholz; J H Saurat; J D Vassalli
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

View more
  85 in total

1.  Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology.

Authors:  E Dublin; A Hanby; N K Patel; R Liebman; D Barnes
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis.

Authors:  Y Friedmann; I Vlodavsky; H Aingorn; A Aviv; T Peretz; I Pecker; O Pappo
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  Alterations in proteolytic activity at low pH and its association with invasion: a theoretical model.

Authors:  S D Webb; J A Sherratt; R G Fish
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

4.  Establishment and characterization of the permanent human cell line C3842 derived from a secondary chondrosarcoma in Ollier's disease.

Authors:  Thomas Kalinski; Sabine Krueger; Antje-Friederike Pelz; Peter Wieacker; Roland Hartig; Martin Röpke; Regine Schneider-Stock; Frank Dombrowski; Albert Roessner
Journal:  Virchows Arch       Date:  2005-02-25       Impact factor: 4.064

5.  Expression of cathepsin B and microvascular density increases with higher grade of astrocytomas.

Authors:  Maode Wang; Jianjian Tang; Shouxun Liu; Daizo Yoshida; Akira Teramoto
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

6.  Protein markers in colorectal cancer: predictors of liver metastasis.

Authors:  C R Berney; R J Fisher; J Yang; P J Russell; P J Crowe
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

7.  Comparison of the effects of the antimetastatic compound ImH[trans-RuCl4(DMSO)Im] (NAMI-A) on the arthritic rat and on MCa mammary carcinoma in mice.

Authors:  G Sava; R Gagliardi; M Cocchietto; K Clerici; I Capozzi; M Marrella; E Alessio; G Mestroni; R Milanino
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

Review 8.  N-Methyl-N-nitrosourea as a mammary carcinogenic agent.

Authors:  Ana I Faustino-Rocha; Rita Ferreira; Paula A Oliveira; Adelina Gama; Mário Ginja
Journal:  Tumour Biol       Date:  2015-09-19

9.  Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex.

Authors:  G Sava; I Capozzi; K Clerici; G Gagliardi; E Alessio; G Mestroni
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

Review 10.  Micronutrient synergy--a new tool in effective control of metastasis and other key mechanisms of cancer.

Authors:  A Niedzwiecki; M W Roomi; T Kalinovsky; M Rath
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.